Abbott Laboratories Price to Sales Ratio 2010-2025 | ABT
Historical PS ratio values for Abbott Laboratories (ABT) over the last 10 years. The current P/S ratio for Abbott Laboratories as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Abbott Laboratories P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-05-02 |
132.82 |
|
5.48 |
| 2025-03-31 |
132.04 |
$24.22 |
5.45 |
| 2024-12-31 |
112.00 |
$23.98 |
4.67 |
| 2024-09-30 |
112.36 |
$23.56 |
4.77 |
| 2024-06-30 |
101.86 |
$23.28 |
4.38 |
| 2024-03-31 |
110.87 |
$23.05 |
4.81 |
| 2023-12-31 |
106.85 |
$22.92 |
4.66 |
| 2023-09-30 |
93.50 |
$22.79 |
4.10 |
| 2023-06-30 |
104.75 |
$22.89 |
4.58 |
| 2023-03-31 |
96.81 |
$23.56 |
4.11 |
| 2022-12-31 |
104.49 |
$24.70 |
4.23 |
| 2022-09-30 |
91.66 |
$25.39 |
3.61 |
| 2022-06-30 |
102.47 |
$25.60 |
4.00 |
| 2022-03-31 |
111.18 |
$24.92 |
4.46 |
| 2021-12-31 |
131.74 |
$24.06 |
5.48 |
| 2021-09-30 |
110.15 |
$23.64 |
4.66 |
| 2021-06-30 |
107.69 |
$22.48 |
4.79 |
| 2021-03-31 |
110.91 |
$20.89 |
5.31 |
| 2020-12-31 |
100.93 |
$19.39 |
5.21 |
| 2020-09-30 |
99.98 |
$18.06 |
5.53 |
| 2020-06-30 |
83.67 |
$17.64 |
4.74 |
| 2020-03-31 |
71.91 |
$18.01 |
3.99 |
| 2019-12-31 |
78.82 |
$17.91 |
4.40 |
| 2019-09-30 |
75.63 |
$17.63 |
4.29 |
| 2019-06-30 |
75.73 |
$17.43 |
4.35 |
| 2019-03-31 |
71.69 |
$17.34 |
4.13 |
| 2018-12-31 |
64.57 |
$17.29 |
3.74 |
| 2018-09-30 |
65.22 |
$17.24 |
3.78 |
| 2018-06-30 |
53.98 |
$16.81 |
3.21 |
| 2018-03-31 |
52.78 |
$16.21 |
3.26 |
| 2017-12-31 |
50.03 |
$15.68 |
3.19 |
| 2017-09-30 |
46.55 |
$14.94 |
3.12 |
| 2017-06-30 |
42.17 |
$14.63 |
2.88 |
| 2017-03-31 |
38.29 |
$14.44 |
2.65 |
| 2016-12-31 |
32.91 |
$14.08 |
2.34 |
| 2016-09-30 |
36.00 |
$13.93 |
2.58 |
| 2016-06-30 |
33.26 |
$13.76 |
2.42 |
| 2016-03-31 |
35.18 |
$13.60 |
2.59 |
| 2015-12-31 |
37.53 |
$13.53 |
2.77 |
| 2015-09-30 |
33.42 |
$13.60 |
2.46 |
| 2015-06-30 |
40.58 |
$13.52 |
3.00 |
| 2015-03-31 |
38.12 |
$13.41 |
2.84 |
| 2014-12-31 |
36.84 |
$13.26 |
2.78 |
| 2014-09-30 |
33.86 |
$12.29 |
2.75 |
| 2014-06-30 |
33.12 |
$12.03 |
2.75 |
| 2014-03-31 |
31.00 |
$12.15 |
2.55 |
| 2013-12-31 |
30.68 |
$12.47 |
2.46 |
| 2013-09-30 |
26.45 |
$11.93 |
2.22 |
| 2013-06-30 |
27.69 |
$12.15 |
2.28 |
| 2013-03-31 |
27.93 |
$12.04 |
2.32 |
| 2012-12-31 |
24.68 |
$11.97 |
2.06 |
| 2012-09-30 |
25.65 |
$16.55 |
1.55 |
| 2012-06-30 |
23.93 |
$19.51 |
1.23 |
| 2012-03-31 |
22.56 |
$22.30 |
1.01 |
| 2011-12-31 |
20.52 |
$24.78 |
0.83 |
| 2011-09-30 |
18.49 |
$24.61 |
0.75 |
| 2011-06-30 |
18.85 |
$23.93 |
0.79 |
| 2011-03-31 |
17.41 |
$23.48 |
0.74 |
| 2010-12-31 |
16.85 |
$22.61 |
0.75 |
| 2010-09-30 |
18.22 |
$21.85 |
0.83 |
| 2010-06-30 |
16.16 |
$21.27 |
0.76 |
| 2010-03-31 |
18.05 |
$20.42 |
0.88 |
| 2009-12-31 |
18.36 |
$19.80 |
0.93 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$231.085B |
$41.950B |
|
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
|
